Stephen A. Bai

1.1k total citations
34 papers, 847 citations indexed

About

Stephen A. Bai is a scholar working on Pharmacology, Oncology and Hematology. According to data from OpenAlex, Stephen A. Bai has authored 34 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Stephen A. Bai's work include Drug Transport and Resistance Mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Stephen A. Bai is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Stephen A. Bai collaborates with scholars based in United States, Germany and Netherlands. Stephen A. Bai's co-authors include Amy Manley, Evan Tzanis, Surya Chitra, Stephen Villano, Lynne Garrity-Ryan, Joyce A. Goldstein, Qinfang Xiang, J. G. Rêves, James R. Jacobs and A. L. Finn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Stephen A. Bai

34 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen A. Bai United States 19 168 157 145 126 115 34 847
J. Heyward Hull United States 12 83 0.5× 120 0.8× 80 0.6× 68 0.5× 85 0.7× 29 767
Samer Mouksassi United States 15 38 0.2× 184 1.2× 207 1.4× 105 0.8× 27 0.2× 37 974
Patricia D. Williams United States 20 44 0.3× 311 2.0× 282 1.9× 195 1.5× 56 0.5× 55 1.1k
Peter R. Gwilt United States 17 78 0.5× 229 1.5× 93 0.6× 207 1.6× 41 0.4× 44 963
Ganesh Cherala United States 18 56 0.3× 234 1.5× 106 0.7× 75 0.6× 102 0.9× 45 1.0k
D. Brockmeier Germany 15 55 0.3× 325 2.1× 148 1.0× 181 1.4× 49 0.4× 44 1.2k
Ganesh S. Moorthy United States 18 33 0.2× 290 1.8× 153 1.1× 124 1.0× 20 0.2× 50 873
Carol Gleason United States 16 45 0.3× 242 1.5× 372 2.6× 155 1.2× 66 0.6× 43 920
Benjamin Weber United States 14 23 0.1× 188 1.2× 103 0.7× 220 1.7× 39 0.3× 34 870
Poe‐Hirr Hsyu United States 16 111 0.7× 222 1.4× 77 0.5× 230 1.8× 35 0.3× 32 892

Countries citing papers authored by Stephen A. Bai

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Bai more than expected).

Fields of papers citing papers by Stephen A. Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Bai. The network helps show where Stephen A. Bai may publish in the future.

Co-authorship network of co-authors of Stephen A. Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Bai. A scholar is included among the top collaborators of Stephen A. Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Bai. Stephen A. Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauben, Manfred, et al.. (2021). Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria. European Journal of Clinical Pharmacology. 77(7). 1019–1028. 4 indexed citations
2.
Hunt, Thomas L., Evan Tzanis, Stephen A. Bai, et al.. (2020). The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 85–92. 16 indexed citations
3.
Bai, Stephen A., Qinfang Xiang, & A. L. Finn. (2016). Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. Clinical Therapeutics. 38(2). 358–369. 27 indexed citations
4.
Tzanis, Evan, Amy Manley, Stephen Villano, et al.. (2016). Effect of Food on the Bioavailability of Omadacycline in Healthy Participants. The Journal of Clinical Pharmacology. 57(3). 321–327. 37 indexed citations
5.
Gadelha, Mônica R., et al.. (2012). A Subcutaneous Octreotide Hydrogel Implant for the Treatment of Acromegaly. Endocrine Practice. 18(6). 870–881. 11 indexed citations
6.
Ruixo, Juan José Pérez, Wojciech Krzyżański, Esther Bouman‐Thio, et al.. (2009). Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects. Clinical Pharmacokinetics. 48(9). 601–613. 31 indexed citations
7.
Bouman‐Thio, Esther, Kari L. Franson, Bruce Miller, et al.. (2008). A Phase I, Single and Fractionated, Ascending‐Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietin Mimetic Antibody Fusion Protein (CNTO 528) in Healthy Male Subjects. The Journal of Clinical Pharmacology. 48(10). 1197–1207. 31 indexed citations
9.
Li, Yunlong, John M. Fevig, Joseph Cacciola, et al.. (2006). Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(19). 5176–5182. 24 indexed citations
10.
Fevig, John M., Joseph Cacciola, Karen A. Rossi, et al.. (2006). Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(14). 3755–3760. 43 indexed citations
11.
Wong, Harvey, Scott Grossman, Stephen A. Bai, et al.. (2004). THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION. Drug Metabolism and Disposition. 32(12). 1359–1369. 21 indexed citations
12.
Hellyer, Peter W., et al.. (1997). Pharmacokinetic-Pharmacodynamic Relations of Losartan and EXP3174 in a Porcine Animal Model. Journal of Cardiovascular Pharmacology. 30(5). 583–590. 11 indexed citations
13.
Farin, Charlotte E., et al.. (1997). Determination of concentration of albendazole sulfoxide in plasma and uterine fluid of heifers. American Journal of Veterinary Research. 58(1). 62–65. 1 indexed citations
14.
Atkins, Clarke E., et al.. (1996). Pharmacokinetic and Pharmacodynamic Properties of Conventional and CD-Formulated Diltiazem in Cats. Journal of Veterinary Internal Medicine. 10(5). 316–320. 12 indexed citations
15.
Atkins, Clarke E., Ronald J. Kanter, Kathy N. Wright, et al.. (1995). Orthodromic Reciprocating Tachycardia and Heart Failure in a Dog With a Concealed Posteroseptal Accessory Pathway. Journal of Veterinary Internal Medicine. 9(1). 43–49. 28 indexed citations
16.
Bai, Stephen A., et al.. (1995). Determination of the stereochemical composition of the major metabolites of verapamil in dog urine with enantioselective liquid chromatographic techniques. Journal of Chromatography B Biomedical Sciences and Applications. 663(1). 91–101. 19 indexed citations
17.
Bai, Stephen A., et al.. (1993). Pharmacokinetics of the enantiomers of verapamil in the dog. Chirality. 5(6). 436–442. 16 indexed citations
18.
Fagan, Timothy C., Thomas Walle, Mary Joan Oexmann, et al.. (1987). Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet. Clinical Pharmacology & Therapeutics. 41(4). 402–406. 42 indexed citations
19.
Bai, Stephen A. & Fred P. Abramson. (1984). Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog. Journal of Pharmacokinetics and Biopharmaceutics. 12(3). 333–349. 4 indexed citations
20.
Abramson, Fred P., Denise E. Robinson, & Stephen A. Bai. (1983). Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog. Biochemical Pharmacology. 32(17). 2618–2620. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026